Antibody Discovery Market Size is valued at USD 7.35 billion in 2023 and is predicted to reach USD 14.52 billion by the year 2031 at a 9.10% CAGR during the forecast period for 2024-2031.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/2287
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global antibody discovery market are:
- Technological advancement
- Increasing awareness of healthcare
- Increasing rates of chronic and infectious diseases
The following are the primary obstacles to the antibody discovery market’s expansion:
- High cost
- Concerns about data security
- Distressed healthcare workers
Future expansion opportunities for the global antibody discovery market include:
- Increasing developments in the field of antibody engineering
- Growing innovative pharmaceuticals
- Increasing g research and development efforts
Market Analysis:
Antibody discovery method enables scientists to produce antibodies that identify and target particular antigens, crucial for creating novel pharmaceuticals, vaccines, diagnostic tools, and other therapeutic uses. Rising spending on antibody discovery research and development, an uptick in the incidence of infectious and chronic diseases, rising public awareness of the need for early diagnosis detection, and the rise of personalized therapy are the primary factors propelling the worldwide antibody discovery market size ahead.
List of Prominent Players in the Antibody Discovery Market:
- Danaher Corporation
- Evotec
- Biocytogen
- Genscript Technology Corporation
- Eurofins Scientific
- Creative Biolabs
- Charles River Laboratories
- Sartorius AG
- Twist Bioscience
- Fairjourney Biologics S.A.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2287
Recent Developments:
- In Mar 2024, Evotec S.E. and Claris Ventures (“Claris”) established an acceleration framework to help bring programs from Claris’s portfolio companies into clinical practice through Evotec’s all-in-one platform.
- In Feb 2024, Danaher Corporation began a strategic partnership with Cincinnati Children’s Hospital Medical Center to improve patient safety by tackling a major reason clinical studies occur. The multi-year partnership is a part of the Danaher Beacons program and aims to enhance liver organoid technology as a drug toxicity screening solution for patient safety. This could hasten the creation of new treatments and prevent yearly losses of billions of dollars in wasted R&D productivity.
- In Oct 2023, Bayer and Twist Bioscience Corporation have entered into a discovery, option, and license agreement for antibodies. Twist Biopharma Solutions, a division of Twist Bioscience, shall utilize its Library of Libraries in accordance with the parameters of the agreement in order to conduct antibody discovery campaigns against Bayer-determined targets. Through the collaboration, Bayer will have the option to license antibodies discovered.As per the stipulations of the agreement, Twist shall be remunerated for commencing research and shall be entitled to fees for reaching research milestones and exercising licensing options.
Antibody Discovery Market Dynamics:
Market Drivers: Increasing Awareness of Health
Increasing public interest in health issues and the need for early diagnostic testing propel the global industry. Personalized medicine’s rising profile among consumers is also likely to fuel the antibody discovery market’s expansion. Biomarkers and genetic tests allow for personalized medicine to be practiced by customizing medical treatments based on existing biological information. A primary goal of personalized medicine is the development of antibodies that can be fine-tuned to address certain diseases.
Challenges: High Cost
The market growth is hindered by the high-cost safety and health standards in the antibody discovery process and the product’s inadequacy to inhibit fogging in settings characterized by extreme temperature swings or high humidity. This is because the industry anticipates that the high expenses associated with the antibody discovery process will limit its widespread adoption. This element anticipates the expansion of the market to be impeded.
North America is Expected to Grow with the Highest CAGR During the Forecast Period
The North America antibody discovery market is likely to register a significant revenue share and develop at a rapid CAGR in the near future. This is because of the growth in cancer rates, the robust antibody discovery business, and the development of cutting-edge research and development technologies. Beyond this, rising rates of chronic illnesses and other cancers are anticipated to drive this market’s expansion in North America throughout the projected year.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/2287
Segmentation of Antibody Discovery Market-
By Methods-
- Phage Display
- Hybridoma
- Others
By Antibody Type-
- Humanized Antibody
- Human Antibody
- Chimeric Antibody
- Murine Antibody
By End User-
- Pharmaceutical and Biotechnology Industry
- Research Laboratory
- Academic Laboratory
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Details insights on this market: https://www.insightaceanalytic.com/report/antibody-discovery-market/2287
Contact Us:
[email protected]
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Information:
Email: [email protected] North America: +1 551 226 6109 Asia: +91 79 72967118 InsightAce
Tags:
BNN, Extended Distribution, Go Media, iCN Internal Distribution, IPS, Research Newswire, English